Acuta Capital Partners’s BELLUS Health Inc. BLU Stock Holding History

Acuta Capital Partners’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-632,500	Closed	-$4.55M	–	45
2023 Q1	$4.55M	Hold	632,500	–	–	3.35%	11
2022 Q4	$5.2M	Sell	632,500 -806,000	-56%	-$7.52M	3.2%	14
2022 Q3	$15.2M	Buy	1,438,500 +622,500	+76%	+$6.62M	6.54%	3
2022 Q2	$7.54M	Hold	816,000	–	–	4.2%	7
2022 Q1	$5.61M	Buy	816,000 +291,000	+55%	+$1.87M	2.62%	13
2021 Q4	$4.23M	Sell	525,000 -1,482,500	-74%	-$9.84M	1.78%	18
2021 Q3	$12.3M	Buy	+2,007,500	New	+$7.61M	4.35%	5
2020 Q3	–	Sell	-765,000	Closed	-$7.87M	–	58
2020 Q2	$7.87M	Sell	765,000 -305,000	-29%	-$3.09M	2.27%	17
2020 Q1	$10.7M	Buy	1,070,000 +260,000	+32%	+$2.32M	5.18%	7
2019 Q4	$6.16M	Buy	810,000 +25,000	+3%	+$171K	1.52%	19
2019 Q3	$5.02M	Buy	+785,000	New	+$5.54M	3.62%	11

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Acuta Capital Partners's BLU Position: Q2 2023 in Review

Acuta Capital Partners sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 632,500 shares — an estimated $4.55M sold.

Acuta Capital Partners first reported a position in BLU in Q3 2019 and held it in 11 quarters. The position peaked at $15.2M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Acuta Capital Partners reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Acuta Capital Partners sold 632,500 BELLUS Health Inc. shares in Q2 2023, an estimated $4.55M.
Acuta Capital Partners first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 11 quarters.
Acuta Capital Partners's BELLUS Health Inc. position peaked at $15.2M in Q3 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Acuta Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.